Predictor of Early Administration of Antibiotics and a Volume Resuscitation for Young Infants with Septic Shock

Osamu Nomura1,2, Takateru Ihara2, Yoshihiko Morikawa3

  • 1Department of Emergency and Disaster Medicine, Hirosaki University, Hirosaki 036-8562, Japan.

Insights

Tachycardia, or rapid heart rate, is a key predictor for completing the 1-hour sepsis bundle in infants. Early recognition of sepsis in young children is critical for timely treatment.

Area of Science:

  • Pediatric Emergency Medicine
  • Infectious Diseases
  • Neonatology

Background:

  • Prompt administration of antibiotics and fluid bolus within 1 hour of sepsis recognition is critical for pediatric patients.
  • Sepsis management in infants requires adherence to a strict 1-hour bundle protocol.
  • Identifying predictors for successful sepsis bundle completion is essential for improving outcomes.

Purpose of the Study:

  • To identify predictors of successful 1-hour sepsis bundle completion in infants with suspected sepsis.
  • To analyze factors influencing the timely administration of critical sepsis interventions.
  • To enhance the understanding of sepsis recognition in young febrile infants.

Main Methods:

  • Observational study utilizing a prospective registry of febrile infants (< 90 days old) presenting to a pediatric emergency department.
  • Inclusion criteria: core body temperature ≥ 38.0 °C or ≤ 36.0 °C.
  • Univariate and logistic regression analyses were performed to determine predictors of 1-hour sepsis bundle completion.

Main Results:

  • A total of 323 infants were registered; 118 with suspected sepsis were analyzed.
  • 38 patients (32.2%) received bundle-compliant treatment.
  • Logistic regression identified heart rate (odds ratio: 1.02; 95% confidence interval: 1.00-1.04) as a significant predictor of 1-hour sepsis bundle completion.

Conclusions:

  • Tachycardia facilitates sepsis recognition and promotes successful completion of the 1-hour sepsis bundle in young infants with suspected septic shock.
  • Heart rate is a significant predictor for timely sepsis care in infants.
  • Findings suggest tachycardia may serve as an indicator for improving team-based sepsis management quality.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
35
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
23
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
22
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
21
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.5K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
70